Get Full access to Top 1000 data, subscribe from only €29

Register Now »
BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.

Financial Data


By Turnover

(€377.3 million)

By Employees

191st in Top Companies By Turnover
  • 236
  • €377.3 million


  • Michael O’Donnell CEO/Managing Director

Latest News


Thanks, You are now signed up to the Top 1000 newsletter!